The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System.

Elias K Spanakis, David L Levitt, Tariq Siddiqui, Lakshmi G Singh, Lillian Pinault, John Sorkin, Guillermo E Umpierrez, Jeffrey C Fink
Author Information
  1. Elias K Spanakis: 1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA. ORCID
  2. David L Levitt: 1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
  3. Tariq Siddiqui: 1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
  4. Lakshmi G Singh: 2 Division of Endocrinology, Baltimore Veterans Administration Medical Center, Baltimore, MD, USA.
  5. Lillian Pinault: 2 Division of Endocrinology, Baltimore Veterans Administration Medical Center, Baltimore, MD, USA.
  6. John Sorkin: 1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
  7. Guillermo E Umpierrez: 3 Division of Endocrinology, Metabolism, and Lipids, Emory University School of Medicine, Atlanta, GA, USA.
  8. Jeffrey C Fink: 1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.

Abstract

BACKGROUND: Few studies have examined the use of continuous glucose monitoring (CGM) devices in the general wards. The aim of this pilot study was to examine whether CGM readings can be successfully transmitted from the bedside to a central monitoring device in the nursing station, and whether a glucose telemetry system can prevent hypoglycemic events.
METHODS: We present pilot data on 5 consecutive insulin treated general medicine patients with type 2 diabetes (T2DM) whose glucose values were observed with CGM (DEXCOM) and the results were transmitted to a central nursing station monitoring system using DEXCOM Follow and Share 2 software. CGM alarms were set-up at glucose <85 mg/dl.
RESULTS: Duration of CGM observation was 4.0 ± 1.6 days (mean ± SD). During CGM, the overall time spent within blood glucose (BG) target of 70-179 mg/dl was 64.68 ± 15% (mean ± SD), on hypoglycemia (<70 mg/dl) was 0.30% ± 0.39, and time spent on hyperglycemia (≥180 mg/dl) was 35.02% ± 15.5. Two patients had 3 actions of prevention of potential hypoglycemia (CGM BG <70 mg/dl for >20 minutes) captured by alarm. No patients had CGM glucose value <54 mg/dl.
CONCLUSIONS: This pilot study indicates that the use of CGM values in hospitalized patients can be successfully transmitted to a monitoring device in the nursing station, improving patient surveillance in insulin treated patients with diabetes.

Keywords

References

  1. Diabetes Care. 2011 Aug;34(8):1723-8 [PMID: 21700919]
  2. J Diabetes Sci Technol. 2017 Sep;11(5):1036-1044 [PMID: 28429611]
  3. Diabetes Care. 2017 Jan;40(1):155-157 [PMID: 27872155]
  4. Diabetes Care. 2005 Apr;28(4):810-5 [PMID: 15793178]
  5. Diabetes Care. 2011 Feb;34(2):256-61 [PMID: 21228246]
  6. Diabetes Technol Ther. 2015 Sep;17(9):611-8 [PMID: 25927357]
  7. BMJ Open Diabetes Res Care. 2014 Jul 21;2(1):e000037 [PMID: 25452874]
  8. Am J Med. 2011 Nov;124(11):1028-35 [PMID: 22017781]
  9. Endocrinol Metab Clin North Am. 1999 Sep;28(3):495-500, v-vi [PMID: 10500927]
  10. J Diabetes Sci Technol. 2017 Mar;11(2):440-441 [PMID: 27543272]
  11. J Hosp Med. 2007 Jul;2(4):234-40 [PMID: 17702035]
  12. J Diabetes Sci Technol. 2017 Sep;11(5):1028-1035 [PMID: 28290224]
  13. Thorax. 2006 Apr;61(4):284-9 [PMID: 16449265]
  14. Diabetes Care. 2007 Sep;30(9):2181-6 [PMID: 17513708]
  15. Jt Comm J Qual Patient Saf. 2012 May;38(5):195-206 [PMID: 22649859]
  16. Diabetes Care. 1999 Sep;22(9):1408-14 [PMID: 10480501]
  17. J Diabetes Sci Technol. 2015 Aug 31;10 (2):325-9 [PMID: 26330394]
  18. Diabetes Care. 2009 Jul;32(7):1153-7 [PMID: 19564471]
  19. Diabetes. 2014 May;63(5):1738-47 [PMID: 24757202]
  20. J Clin Endocrinol Metab. 2009 Feb;94(2):564-9 [PMID: 19017758]
  21. J Diabetes Sci Technol. 2012 Sep 01;6(5):1022-9 [PMID: 23063027]
  22. Diabetes Care. 2003 May;26(5):1518-24 [PMID: 12716815]
  23. J Clin Endocrinol Metab. 2012 Jan;97(1):16-38 [PMID: 22223765]
  24. Diabetes Care. 2014 Feb;37(2):516-20 [PMID: 24041680]
  25. Diabetes Care. 2015 Dec;38(12 ):2211-6 [PMID: 26459273]
  26. J Clin Endocrinol Metab. 2011 Oct;96(10):2968-79 [PMID: 21976745]
  27. J Clin Endocrinol Metab. 2002 Mar;87(3):978-82 [PMID: 11889147]
  28. Endocr Pract. 2014 Sep;20(9):876-83 [PMID: 24641927]
  29. Diabetes Technol Ther. 2013 Mar;15(3):241-5 [PMID: 23360391]

Grants

  1. P30 DK111024/NIDDK NIH HHS
  2. R18 DK110955/NIDDK NIH HHS
  3. P30 AG028747/NIA NIH HHS
  4. R01 HL127422/NHLBI NIH HHS
  5. P30 DK072488/NIDDK NIH HHS
  6. R34 DK102177/NIDDK NIH HHS
  7. UL1 RR025008/NCRR NIH HHS

MeSH Term

Aged
Blood Glucose
Female
Humans
Hypoglycemia
Male
Middle Aged
Pilot Projects
Telemetry

Chemicals

Blood Glucose

Word Cloud

Created with Highcharts 10.0.0CGMglucosemg/dl±monitoringpatientspilotcantransmittednursingstation2diabetes0hypoglycemiausecontinuousgeneralstudywhethersuccessfullycentraldevicetelemetrysystem5insulintreatedtypevaluesDEXCOMmeanSDtimespentBG<70GlucoseBACKGROUND:studiesexamineddeviceswardsaimexaminereadingsbedsidepreventhypoglycemiceventsMETHODS:presentdataconsecutivemedicineT2DMwhoseobservedresultsusingFollowSharesoftwarealarmsset-up<85RESULTS:Durationobservation416daysoverallwithinbloodtarget70-179646815%30%39hyperglycemia≥1803502%15Two3actionspreventionpotential>20minutescapturedalarmvalue<54CONCLUSIONS:indicateshospitalizedimprovingpatientsurveillanceEffectContinuousMonitoringPreventingInpatientHypoglycemiaGeneralWards:TelemetrySysteminpatient

Similar Articles

Cited By